CHO Pharma, Inc. (6586.TWO)

TWD 43.1

(0.47%)

Long Term Debt Summary of CHO Pharma, Inc.

  • CHO Pharma, Inc.'s latest annual long term debt in 2023 was - TWD , down 0.0% from previous year.
  • CHO Pharma, Inc.'s latest quarterly long term debt in 2024 Q2 was 21.77 Million TWD , down 0.0% from previous quarter.
  • CHO Pharma, Inc. reported annual long term debt of - TWD in 2022, down -100.0% from previous year.
  • CHO Pharma, Inc. reported annual long term debt of 11.69 Million TWD in 2021, down -54.44% from previous year.
  • CHO Pharma, Inc. reported quarterly long term debt of 21.77 Million TWD for 2024 Q1, down 0.0% from previous quarter.
  • CHO Pharma, Inc. reported quarterly long term debt of - TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of CHO Pharma, Inc. (2023 - 2019)

Historical Annual Long Term Debt of CHO Pharma, Inc. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - TWD 0.0%
2022 - TWD -100.0%
2021 11.69 Million TWD -54.44%
2020 25.67 Million TWD -11.58%
2019 29.03 Million TWD 0.0%

Peer Long Term Debt Comparison of CHO Pharma, Inc.

Name Long Term Debt Long Term Debt Difference
SYN-TECH Chem. & Pharm. Co., Ltd. 60.65 Million TWD 100.0%
Level Biotechnology Inc. 9.88 Million TWD 100.0%
Sagittarius Life Science Corp 6.25 Million TWD 100.0%
NeoCore Technology Co., Ltd. 33.65 Million TWD 100.0%
TaiMed Biologics Inc. 521.7 Million TWD 100.0%
GlycoNex Incorporation - TWD NaN%
VBI - TWD NaN%
GeneReach Biotechnology Corp. 97.74 Million TWD 100.0%
Taiwan Advance Bio-Pharmaceutical Inc. 86.89 Million TWD 100.0%
Visgeneer Inc. 114.17 Million TWD 100.0%
Mycenax Biotech Inc. 569.78 Million TWD 100.0%
Sunmax Biotechnology Co., Ltd. 144.77 Million TWD 100.0%
G&E Herbal Biotechnology Co., Ltd. 1.29 Million TWD 100.0%
Medigen Vaccine Biologics Corporation 254.35 Million TWD 100.0%
TaiwanJ Pharmaceuticals Co., Ltd. 472 Thousand TWD 100.0%
Enimmune corporation 1.75 Million TWD 100.0%
TaiRx, Inc. 8.96 Million TWD 100.0%
EirGenix Inc. 436.54 Million TWD 100.0%
BioLASCO Taiwan Co., Ltd. 51.43 Million TWD 100.0%
Sunny Pharmtech Inc. 376.29 Million TWD 100.0%
Lin BioScience, Inc. 29.02 Million TWD 100.0%
BioGend Therapeutics Co., Ltd. 9.44 Million TWD 100.0%
Feng Chi Biotech Corp. 8.14 Million TWD 100.0%
Bio Preventive Medicine Corp. 106.2 Million TWD 100.0%
Lukas Biomedical Inc. 69.9 Million TWD 100.0%
RBC Bioscience Corporation 412.59 Million TWD 100.0%
BiOptic Inc. 85.79 Million TWD 100.0%
BRIM Biotechnology, Inc. 108 Thousand TWD 100.0%
Shine-On BioMedical Co.,Ltd. - TWD NaN%
Great Novel Therapeutics Biotech & Medicals 10.88 Million TWD 100.0%
Syngen Biotech Co.,Ltd. 386.07 Million TWD 100.0%
Anti-Microbial Savior BioteQ Co., Ltd - TWD NaN%
SynCore Biotechnology Co.,Ltd - TWD NaN%
Genomics BioSci & Tech. Co.,Ltd. 222.24 Million TWD 100.0%
Neith Corporation 714 Thousand TWD 100.0%
Advagene Biopharma Co., Ltd. - TWD NaN%
NaviFUS Corp. 25.83 Million TWD 100.0%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 366 Million TWD 100.0%
Sinew Pharma Inc. - TWD NaN%
Andros Pharmaceuticals Co.,Ltd 22.02 Million TWD 100.0%
Greenyn Biotechnology Co., Ltd 55.91 Million TWD 100.0%
Lumosa Therapeutics Co., Ltd. 8.11 Million TWD 100.0%
AP Biosciences Inc 70.42 Million TWD 100.0%
Medigen Biotechnology Corp. 449.09 Million TWD 100.0%
3D Global Biotech Inc. 4.08 Million TWD 100.0%
Pharmosa Biopharm Inc. 118.41 Million TWD 100.0%
Intech Biopharm Corporation 970.4 Million TWD 100.0%
Oneness Biotech Co., Ltd. 397.95 Million TWD 100.0%
Eusol Biotech Co.,Ltd. 1.6 Million TWD 100.0%
TWi Biotechnology, Inc. 5.6 Million TWD 100.0%
Ever Supreme Bio Technology Co., Ltd 503 Thousand TWD 100.0%
TCI GENE Inc. - TWD NaN%
MegaPro Biomedical Co., Ltd 5.62 Million TWD 100.0%
Senhwa Biosciences, Inc. 3.28 Million TWD 100.0%
Taiwan Bio Therapeutics Co., Ltd 250.51 Million TWD 100.0%
NatureWise Biotech & Medicals Corporation 3.26 Million TWD 100.0%
PharmaEngine, Inc. 7.14 Million TWD 100.0%
Savior Lifetec Corporation 257.03 Million TWD 100.0%
TaiGen Biopharmaceuticals Holdings Limited 58.71 Million TWD 100.0%
OBI Pharma, Inc. 439.88 Million TWD 100.0%
Meribank Biotech Co., Ltd 14.81 Million TWD 100.0%
Acepodia, Inc. 233.45 Million TWD 100.0%
Caliway Biopharmaceuticals Co., Ltd. 11.87 Million TWD 100.0%